Xcellerate Clinical Trial Optimization Trademark Details

Xcellerate Clinical Trial Optimization was registered on Tuesday, May 22, 2012 and is currently owned by Labcorp Drug Development Inc. under the registration number 4145934 . This mark is alive with a status of Registered. The last case file activity for this mark occured 12 years ago on Tuesday, May 22, 2012, according to the United State Patent & Trademark Office
Word Mark Xcellerate Clinical Trial Optimization
Status Alive Registered 700 — Registered

Current Owner

Labcorp Drug Development Inc. of Princeton, NJ

View all trademarks for Labcorp Drug Development Inc.
Other Trademarks for Labcorp Drug Development Inc.
Serial Number 85421531
Registration Number 4145934
Status Date Tuesday, May 22, 2012
Filing Date Tuesday, May 22, 2012
Registration Date Tuesday, May 22, 2012
Attorney Glenn A. Gundersen

Correspondent

GLENN A. GUNDERSEN
DECHERT LLP
2929 ARCH ST STE 400
PHILADELPHIA, PA 19104-2808

Case File Statements

Disclaimer with Predetermined Text "Clinical Trial Optimization"
Goods & Services Conducting Clinical Trials of Pharmaceuticals and Medical Devices; Scientific Research Services, Namely, Tracking, Analyzing, Forecasting, and Reporting Data in the Field of Clinical Trials of Pharmaceuticals and Medical Devices
Pseudo Mark Excellerate Clinical Trial Optimization

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, September 16, 2011
First Use Anywhere Tuesday, March 1, 2011
First Use In Commerce Tuesday, March 1, 2011
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.